MPWT
FATE icon

MassMutual Private Wealth & Trust’s Fate Therapeutics FATE Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-60
Closed -$1K – 1708
2022
Q3 		$1K Buy
+60
New +$1.73K ﹤0.01% 1420
2022
Q2 		– Sell
-23
Closed -$1K – 1575
2022
Q1 		$1K Buy
+23
New +$891 ﹤0.01% 1316

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

MassMutual Private Wealth & Trust's FATE Position: Q4 2022 in Review

MassMutual Private Wealth & Trust sold out of Fate Therapeutics (FATE) in Q4 2022, closing a stake of 60 shares — an estimated $1K sold.

MassMutual Private Wealth & Trust first reported a position in FATE in Q1 2022 and held it in 2 quarters. The position peaked at $1K in Q3 2022. 227 funds tracked by Wall St. Rank hold FATE as of Q4 2022.

  • MassMutual Private Wealth & Trust reported no remaining Fate Therapeutics position as of Q4 2022 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 60 Fate Therapeutics shares in Q4 2022, an estimated $1K.
  • MassMutual Private Wealth & Trust first reported a position in Fate Therapeutics in Q1 2022 and held it in 2 quarters.
  • MassMutual Private Wealth & Trust's Fate Therapeutics position peaked at $1K in Q3 2022.
  • 227 funds tracked by Wall St. Rank held Fate Therapeutics as of Q4 2022.

Based on MassMutual Private Wealth & Trust's 13F filing for Q4 2022, filed 6 Jan 2023.